To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.
- Sponsor
- Rep. Conaway, Herbert C. [D-NJ-3]
- Committees
- Veterans' Affairs Committee (primary)
- Last action
- May 14, 2026
Bottom line
This bill aims to increase immediate access to opioid antagonists for veterans by removing prescription and copayment requirements, directly addressing the opioid crisis within the veteran community.
What it actually does
This bill directs the Secretary of Veterans Affairs to furnish opioid antagonists to veterans without requiring a prescription. Additionally, it amends existing law to eliminate any copayment requirement for veterans receiving these life-saving medications. The aim is to remove significant barriers to accessing treatment for opioid overdose.
Proponents argue
Supporters argue that this bill is a critical step in combating the opioid overdose crisis among veterans by making life-saving medication readily available. They contend that removing prescription barriers and financial costs will ensure that veterans at risk, or those who may encounter someone experiencing an overdose, can quickly obtain and administer these antagonists, thereby saving lives and reducing the devastating impact of opioid addiction.
Opponents contend
Direct opposition to providing opioid antagonists is rare due to their life-saving nature. However, some might raise concerns about the broader implications for VA healthcare resource allocation or the potential for dispensing without adequate patient education or follow-up care, though these are typically minor compared to the public health benefits.
The bill is very short and clear, making it highly accessible for any reader to understand its provisions quickly.
Section 1(a)
Direct Provision of Opioid Antagonists Without Prescription
This provision mandates that the Department of Veterans Affairs (VA) must provide opioid antagonists to any veteran without requiring a doctor's prescription. This means veterans can obtain these medications directly from the VA, bypassing the need for a prior medical consultation or formal prescription process, thereby streamlining access to emergency overdose treatment.
Supporters argue
Proponents argue that removing the prescription requirement is crucial for immediate intervention in opioid overdose situations, where every minute counts. They contend it empowers veterans and their families to act quickly, aligning with public health strategies that advocate for widespread availability of opioid antagonists to reduce overdose fatalities.
Critics contend
While direct opposition to this provision is minimal due to the life-saving nature of opioid antagonists, some might express concerns about the potential for reduced clinical oversight or the need for robust patient education accompanying direct dispensing to ensure safe and appropriate use.
Tradeoffs
The provision balances the critical need for immediate access to life-saving medication against traditional medical protocols that typically require a prescription for controlled substances or potent drugs, navigating the tension between public health urgency and clinical oversight.
Section 1(b)
Elimination of Copayment for Opioid Antagonists
This provision amends existing law to ensure that veterans will not be required to pay any copayment when furnished an opioid antagonist by the VA. By striking the language that allows for copayments in certain circumstances, the bill makes these medications entirely free of charge for veterans, removing financial barriers to access.